Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026)
Fortrea Holdings (FTRE) reported Interest & Investment Income of -$19.1 million for Q1 2026, up 14.35% on a YoY basis from -$16.7 million in Q1 2025, and up 17.67% quarter-over-quarter from -$23.2 million in Q4 2025.
Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026) Analysis & Trends
Fortrea Holdings has reported Interest & Investment Income for 4 years, with the latest figure at -$19.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 14.35% year-over-year to -$19.1 million; the trailing twelve-month figure through Mar 2026 stood at -$88.2 million (up 21.11% YoY), and the FY2025 full-year result was -$91.4 million, up 26.17% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$19.1 million, up from -$23.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was -$700000.0 in Q2 2023, with the low at -$45.2 million in Q2 2024.
- Historically, Interest & Investment Income has averaged -$25.3 million across 4 years, with a median of -$22.9 million in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income sank 6357.14% — and 2025, when it soared 48.45%.
- Fortrea Holdings' Interest & Investment Income stood at -$34.5 million in 2023, then jumped by 36.52% to -$21.9 million in 2024, then declined by 5.94% to -$23.2 million in 2025, then increased by 17.67% to -$19.1 million in 2026.
- The last three Interest & Investment Income figures came in at -$19.1 million (Q1 2026), -$23.2 million (Q4 2025), and -$22.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -19.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.10 Mn |
| Dec 31, 2025 | -23.20 Mn |
| Sep 30, 2025 | -22.60 Mn |
| Jun 30, 2025 | -23.30 Mn |
| Mar 31, 2025 | -22.30 Mn |
| Dec 31, 2024 | -21.90 Mn |
| Sep 30, 2024 | -22.40 Mn |
| Jun 30, 2024 | -45.20 Mn |
| Mar 31, 2024 | -34.30 Mn |
| Dec 31, 2023 | -34.50 Mn |
| Sep 30, 2023 | -34.60 Mn |
| Jun 30, 2023 | -700,000.00 |